Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (3)
  • 2025 (10)
  • 2024 (6)
  • 2023 (12)
  • 2022 (8)
  • 2021 (7)
  • 2019 (2)

Subject

  • Drug Trafficking (368)
  • Synthetic drugs (310)
  • Fake Pills (219)
  • Guns/Weapons (98)
  • Seizures (Drugs/Property) (87)
  • OCDETF/Task Force (70)
  • Take Back Day (51)
  • Guilty Plea (40)
  • Diversion Division (35)
  • Outreach/Drug Prevention (34)
  • Arrests/Convictions - Major (22)
  • Major Law Enforcement Operation (18)
  • Overdose (18)
  • Pharmaceuticals/Pharmacists/Physicians (18)
  • Public and Media Affairs - also see Congressional Affairs (17)
  • Fentanyl Awareness (16)
  • Money Laundering (16)
  • Press Conferences (16)
  • HIDTA (14)
  • Gangs (13)
  • Congressional Affairs (12)
  • One Pill Can Kill (12)
  • Prevention/Education - DEA websites GSAD, JTT etc (9)
  • Red Ribbon (9)
  • Counterfeit Pills (7)
  • Extraditions (6)
  • Fentanyl Free America (5)
  • Intergovernmental Affairs (4)
  • International/Foreign Operations (4)
  • Narcoterrorism (4)
  • Critical Incident (3)
  • Dark Web- Internet Trafficking (3)
  • Task Forces/Task Force Officers (3)
  • Campaigns (2)
  • Scam Calls (2)
  • Terrorism (2)
  • Asset Forfeiture (1)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)
  • Prescription Drugs (48)

Drug Name

  • Opioids (7)
  • Oxycodone (7)
  • Fentanyl (6)
  • Hydromorphone (5)
  • Benzodiazepines (3)
  • Methadone (2)
  • Methamphetamine (2)
  • Amphetamines (1)
  • Cocaine (1)
  • GHB (1)
  • Heroin (1)
  • Ketamine (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)
  • Steroids (1)

Field Division

  • Washington, DC (45)
  • St. Louis (39)
  • New York (35)
  • New England (24)
  • Atlanta (19)
  • Miami (19)
  • Chicago (16)
  • Dallas (15)
  • New Jersey (15)
  • El Paso (14)
  • Houston (12)
  • San Francisco (12)
  • Louisville (10)
  • Los Angeles (9)
  • Omaha (9)
  • New Orleans (8)
  • Phoenix (6)
  • Rocky Mountain (6)
  • San Diego (6)
  • Detroit (3)
  • Philadelphia (1)
  • Seattle (25)
  • Headquarters (23)
Clear All Results
48 Results - Showing 1 to 10
PRESS RELEASE

Former Anesthesiology Resident Who Worked at Seattle Children's, UW Medicine, and Harborview Medical Center, Sentenced for Stealing and Using Narcotic Pain Medicine While on Duty

SEATTLE – A 36-year-old former anesthesiology resident at Seattle Children’s Hospital and Harborview and University of Washington Medical Centers was sentenced today in U.S. District Court in Seattle to one year of supervised release including 200 hours of community service for diverting narcotic pain medication to his own use while...
PRESS RELEASE

Portland Veterinarian Sentenced for Diverting Controlled Substances for Personal Use

PORTLAND, Ore. — Dr. Brenda Brown-Carlson, a Portland veterinarian, was sentenced to 60 months of supervised probation on January 13, 2026, in Multnomah County Circuit Court as part of a plea agreement. Brown-Carlson admitted to diverting controlled substances for her personal use and replacing them with saline, impacting the treatment...
PRESS RELEASE

DEA Releases 2026 Aggregate Production Quotas

WASHINGTON – This week the U.S. Drug Enforcement Administration released the established aggregate production quotas (APQ) for schedule I and II controlled substances and assessment of annual needs (AAN) for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine for 2026. “DEA is committed to ensuring that patients can access the...
PRESS RELEASE

DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care

WASHINGTON – The U.S. Drug Enforcement Administration, in partnership with the Department of Health and Human Services (HHS), has issued a Fourth Temporary Extension of the COVID-19 Telemedicine Flexibilities for the Prescription of Controlled Medications , extending the current telemedicine flexibilities through December 31, 2026. Under these telemedicine flexibilities, DEA-registered...
PRESS RELEASE

Former Ellensburg Doctor Indicted on 26 Felony Counts for Falsifying and Issuing Commercial Driver’s Licenses and Prescriptions for Controlled Substances

YAKIMA, Wash. – On November 14, 2025, a federal grand jury for the Eastern District of Washington returned an Indictment charging Anna Elperin, age 42, with 26 felony counts relating to prescriptions for controlled substances and Department of Transportation commercial driver’s licenses physical examinations Elperin wrote and performed at her...
PRESS RELEASE

DEA Hosts the 29th National Prescription Drug Take Back Day on Saturday, October 25th

WASHINGTON –The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription Drug Take...
PRESS RELEASE

DEA Hosts the 29th National Prescription Drug Take Back Day on Saturday, October 25th

SEATTLE –The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription Drug Take...
PRESS RELEASE

UW Medicine Resident Physician at Seattle Children’s Hospital Charged for Diverting Fentanyl

SEATTLE, Wash.--Dr. Andrew Voegel-Podadera, 35, a resident physician at the University of Washington Medical School who worked at Seattle Children’s Hospital, UW Medicine, and Harborview Medical Center is charged with two counts of Acquiring a Controlled Substance by Misrepresentation, Fraud, Deception, and Subterfuge. On June 24th, 2025, DEA Seattle Diversion...
PRESS RELEASE

DEA Revokes Registration for Seattle Nurse Who Wrote Prescriptions for Controlled Substances After His State License Was Suspended

SEATTLE, Wash.-- On June 20, 2025, the Drug Enforcement Administration (DEA) revoked the DEA registration of registered nurse practitioner (ARNP) Scott Eric Hansen. Hansen’s state license was indefinitely suspended in 2024 after a finding that his ability to issue controlled substance prescriptions posed an immediate danger to public health and...
PRESS RELEASE

DEA Releases 2025 National Drug Threat Assessment

WASHINGTON – The U.S. Drug Enforcement Administration today announced the release of the 2025 National Drug Threat Assessment (NDTA), DEA’s comprehensive review of the threats posed to the United States by deadly illicit drugs and the violent domestic and international drug trafficking organizations responsible for producing and trafficking the drugs...

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster